US Stock MarketDetailed Quotes

CCCC C4 Therapeutics

Watchlist
  • 6.320
  • +0.150+2.43%
Close Apr 29 16:00 ET
  • 6.360
  • +0.040+0.63%
Post 17:27 ET
433.56MMarket Cap-2367P/E (TTM)

C4 Therapeutics Key Stats

C4 Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

3.26M

+14.26%
EPS(YoY)

-0.68

+10.53%

Buy

Mar 31, 2024

C4 Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.883M--
--2024/Q1-- / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--
--2022/Q17.654M / 8.050M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 3.883M--
--2024/Q1-- / 9.283M--
--2023/Q43.261M / 3.213M--
--2023/Q311.072M / 5.460M--
--2023/Q22.664M / 6.439M--
--2023/Q13.759M / 5.463M--
--2022/Q42.854M / 10.943M--
--2022/Q36.754M / 9.262M--
--2022/Q213.834M / 8.507M--
--2022/Q17.654M / 8.050M--

Unlock Free Earnings Estimates

C4 Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Mar 31, 2024

Buy

  • Buy

    62.50%
  • Hold

    37.50%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg